Device type · GWL
Amplifier, Physiological Signal
Last checked: Nov 19, 2026Source: openFDAMethods & limitations
Product code
GWL
Neurology
Device class
Class II
FDA decisions since 2015
16
510(k), De Novo and PMA
Adverse event reports
0
Received Nov 1, 2025 to Nov 19, 2026
How FDA classifies it
- Device type
- Amplifier, Physiological Signal
- Product code
- GWL
- Device class
- Class II
- Review panel
- Neurology
- Regulation
- 21 CFR 882.1835
- Specialty
- Neurology & Neurosurgery
- FDA record
- Classification database entry for GWL
Latest FDA decisions
The 8 newest of 16 since 2015.
- PolySense510(k)
K260648 · Decided Oct 30, 2026 · 245 days after receipt
Device type: Amplifier, Physiological Signal (GWL) · Neurology & Neurosurgery
- Delphi Amplifier510(k)
K243746 · Decided Mar 12, 2025 · 97 days after receipt
Device type: Amplifier, Physiological Signal (GWL) · Neurology & Neurosurgery
K242832 · Decided Dec 12, 2024 · 84 days after receipt
Device type: Amplifier, Physiological Signal (GWL) · Neurology & Neurosurgery
13 more FDA decisions with a free account
Reports received
0
Received Nov 1, 2025 to Nov 19, 2026
Malfunction reports
0
Injury reports
0
Death reports
0
Adverse event reports received per month
By the date FDA received each report, stacked by event type. The newest month is incomplete.
No reports to chart for this view.
Manufacturers named most often
Last 12 months. Bigger sellers get more reports. This is not a ranking of safety.
No manufacturers to rank.
Device problems as coded
Last 12 months. FDA's terms. A report can carry several.
No device problems coded.
Patient problems as coded
Last 12 months. FDA's terms. A report can carry several.
No patient problems coded.
Recent recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
Z-2763-2016 · Started Aug 10, 2016 · Posted by FDA Sep 8, 2016
Reason given: Blackrock Microsystems, LLC announces a voluntary field action for the Blackrock NeuroPort Biopotential Signal Processing System because the Neural Signal Amplifier and the Patient Cable are incorrectly labeled as Type CF Applied Parts.
Cause as FDA categorized it: Labeling False and Misleading
Z-2764-2016 · Started Aug 10, 2016 · Posted by FDA Sep 8, 2016
Reason given: Blackrock Microsystems, LLC announces a voluntary field action for the Blackrock NeuroPort Biopotential Signal Processing System because the Neural Signal Amplifier and the Patient Cable are incorrectly labeled as Type CF Applied Parts.
Cause as FDA categorized it: Labeling False and Misleading
Z-0946-2013 · Started Feb 27, 2013 · Posted by FDA Mar 13, 2013
Reason given: Natus Neurology Incorporated is recalling the Nicolet EEG Wireless Amplifier which may overheat and become uncomfortable to touch around the area of the on/off button. The overheating may result in discomfort ranging from too hot up to the potential for a burn.
Cause as FDA categorized it: Nonconforming Material/Component
1 more recall records with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.